6,075.00

Content Details
Information on this page was last modified on : 2021/05/08 3:47:44 PM

CELL-AID DEPOT 150mcg Injection 1s

Interferon Alpha 2b:150mcg | Immunomodulators

Alternate brands of CELL-AID DEPOT 150mcg Injection 1s

Brand Name Price Savings
RENEW DEPOT 150mcg Injection 1s  6,075.00 You can save 0
List of alternate brands

Manufactured / Marketed By : Werrick

Product Form : Injection

Pack Size : 1s

Ingredients : Interferon Alpha 2b:150mcg

Generic Category : Immunomodulators

How it works

CELL-AID DEPOT 150mcg Injection 1s work by affecting cell function/growth and the body's natural defenses (immune system) in many ways.

Side effects

Major & minor side effects for CELL-AID DEPOT 150mcg Injection 1s

  • Abdominal and stomach pain
  • Anxiety
  • Black or tarry stools
  • Bloody diarrhea
  • Nausea and vomiting
  • Mood swings
  • Chills and fever
  • Cough or hoarseness
  • Irritability
  • Unusual tiredness or weakness

Uses of CELL-AID DEPOT 150mcg Injection 1s

What is it prescribed for?

  • Chronic Hepatitis C

    This medicine is used alone or in combination with ribavirin to treat chronic hepatitis C, which is a liver disease caused by hepatitis C virus (HCV).

  • Melanoma

    This medicine is used as an adjuvant therapy to prevent recurrence of melanoma (a type of skin cancer), even after it has been removed by surgery.

  • Chronic Hepatitis B

    As a weekly subcutaneous injection, this medicine is used alone or in combination with nucleotide analogues (Entecavir, Tenofovir, etc.) to treat chronic hepatitis B (a liver disease caused by hepatitis B virus) for 48 weeks.

Concerns

Frequently asked questions

  • Onset of action

    The peak plasma levels of this medicine can be observed in 15-44 hours on subcutaneous administration.

  • Duration of Effect

    The amount of time for which this medicine remains active in the body is not clinically established.

  • Safe with Alchohol?

    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

  • Is it habit forming?

    No habit-forming tendencies were reported.

  • Usage in pregnancy?

    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

  • Usage while breast-feeding?

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

When not to use?

  • Allergy

    This medicine is not recommended for use in patients with a known allergy to CELL-AID DEPOT 150mcg Injection 1s or any other inactive ingredients present along with it.

  • Autoimmune hepatitis

    This medicine is not recommended for use in patients with autoimmune hepatitis due to the increased risk of worsening of the patient's condition.

  • Liver cirrhosis

    This medicine is not recommended for use in patients with liver cirrhosis associated with alcohol or any other causes with a Child-Pugh score ≥ 6 due to the increased risk of worsening of the patient's condition.

Warnings

Warnings for special population
  • Pregnancy

    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

  • Breast-feeding

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

General Warnings
  • Neuropsychiatric reaction

    This medicine can cause life-threatening or fatal neuropsychiatric reactions. These include suicide, suicidal tendency, depression, and an increased risk of relapse of recovering drug addicts. Report any such incidence to the doctor so that counseling can be performed at regular intervals. Monitoring the patients for signs and symptoms of depression and other psychiatric symptoms every 3 weeks during the first 8 weeks of treatment and every 6 months thereafter is recommended.

  • Heart diseases

    This medicine should be used with caution in patients with cardiac dysfunctions such as hypertension, arrhythmias, angina, myocardial infarction, cardiomyopathy, and congestive heart failure due to increased risk of worsening of the patient's condition. Close monitoring of cardiac function, appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • Bone marrow suppression

    This medicine can cause bone marrow depression. Severe decreases in white blood cell or platelet counts have been reported with this medicine. Close monitoring of blood cell count and symptoms for any infections should be monitored while receiving this medicine. An alternative treatment option should be considered in some cases based on the clinical condition.

  • Growth retardation in pediatric patients

    Use of Combination therapy with this medicine is reported to cause growth inhibition and weight loss in pediatric patients.

  • Hepatic decompensation

    Cirrhotic chronic hepatitis C patients co-infected with HIV receiving highly active antiretroviral therapy (HAART) and CELL-AID DEPOT 150mcg Injection 1s with or without ribavirin appear to be at increased risk for development of hepatic decompensation compared to patients not receiving HAART. Close monitoring of hepatic function during treatment is necessary and discontinue immediately if decompensation (A Child-Pugh score greater than 6) observed.

  • Driving or Operating machinery

    Use of this medicine may cause blurred vision or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Dosage

  • Missed Dose

    Pen: The missed dose of this medicine should be administered as soon as possible. It is advisable to skip the missed dose if it is already the time for your next scheduled dose. Do not double the dose to make up for the missed dose. Vials: Since this medicine is administered by a qualified healthcare professional in the clinical or hospital setting, the likelihood of a missed dose is very low. If you miss an appointment for a scheduled dose of this medicine, contact your doctor immediately for further instructions.

  • Overdose

    Pen: Seek emergency medical treatment or contact the doctor in case of an overdose. Vials: Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.

Interactions

Interaction with Medicines
  • Tramadol severe
  • Leflunomide severe
  • Bupropion severe
  • Tizanidine severe
  • Clozapine severe
Disease interactions
  • severe

    This medicine should be used with caution in patients with renal disease due to the increased risk of worsening of the patient's condition. Close monitoring of renal function, appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • severe

    This medicine should be used with extreme caution or should be avoided in patients with autoimmune diseases due to increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • severe

    This medicine should be used with caution in patients with cardiac dysfunctions such as hypertension, arrhythmias, angina, myocardial infarction, cardiomyopathy, and congestive heart failure due to increased risk of worsening of the patient's condition. Close monitoring of cardiac function, appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • severe

    This medicine should be used with caution in patients with seizures, psychiatric disorders or conditions affecting posture or gait due to increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • severe

    This medicine should be used with caution in patients with thyroid abnormalities due to increased risk of worsening of the patient's condition. Close monitoring of the thyroid function, appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • moderate

    This medicine should be used with caution in patients with fatal and nonfatal ulcerative or hemorrhagic/ischemic colitis due to increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • moderate

    This medicine should be used with caution in patients with diabetes mellitus due to increased risk of precipitation of ketoacidosis. Close monitoring of blood glucose levels, appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • moderate

    This medicine should be used with caution in patients with bone marrow suppression or decreased blood cell count due to increased risk of worsening of the patient's condition. Close monitoring of blood cell count, appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • moderate

    This medicine should be used with caution in patients with eye disorders due to an increased risk of worsening of the patient's condition. Patients should have periodic eye examinations during the treatment. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • moderate

    This medicine should be used with caution in patients with lung diseases due to increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

General Instructions

Some formulations of this medicine can be self administered at home while others are to be administered in the hospital setting. Prefilled pen: Administer this medicine as advised by the doctor. It should be given in multiple cycles along with other antiviral agents. It is important to receive every scheduled dose. The blood cells, liver function, cardiac function, renal function should be assessed before starting the treatment. Any signs and symptoms of heart and liver dysfunction should be reported to the doctor on priority. Vials: This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.

Other details

  • Usage does not depend on food timings
  • To be taken as instructed by doctor
  • May cause sleepiness

References

Additional Information:

One of the following licensed pharmacy from the nearest location will deliver CELL-AID DEPOT 150mcg Injection 1s. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Want to share this information?
Facebook
Twitter
LinkedIn
Something doesn't feel right ?

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions

Reviews

There are no reviews yet.

Be the first to review “CELL-AID DEPOT 150mcg Injection 1s”
Shopping Cart